Comparing preoperative and pathologic tumor sizes in breast cancer
Concordance Between Preoperative Assessments and Pathologic Size Measurements in Breast Cancer: a Prospective Observational Study
Incheon St.Mary's Hospital · NCT06505577
This study is trying to see if combining different tests and factors can help doctors better plan breast cancer surgeries by predicting how much of the tumor needs to be removed.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | Incheon St.Mary's Hospital (other) |
| Locations | 1 site (Incheon) |
| Trial ID | NCT06505577 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on breast cancer patients scheduled for surgical resection, aiming to improve surgical planning by accurately predicting the extent of tumor resection. It integrates various predictive factors, including imaging studies, physical examinations, and tumor molecular subtypes, to derive a model that can guide surgeons in determining the optimal resection extent. By analyzing the interplay of these factors in real-world clinical settings, the study seeks to minimize reoperation rates and enhance patient outcomes. The findings could lead to better management strategies for breast cancer surgeries.
Who should consider this trial
Good fit: Ideal candidates include adult patients diagnosed with invasive or in situ breast cancer who are scheduled for surgical resection.
Not a fit: Patients with recurrent breast cancer or those who did not undergo surgery will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to reduced reoperation rates and improved surgical outcomes for breast cancer patients.
How similar studies have performed: While similar studies have explored predictive factors in breast cancer surgery, this approach aims to integrate multiple factors in a novel way to enhance clinical decision-making.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Adult patients (≥ 19 years old) diagnosed with breast cancer (invasive and in situ). Patients scheduled for surgical resection of the tumor Availability of both preoperative tumor size assessments and pathologic measurements post-surgery Exclusion Criteria: Patients with recurrent breast cancer Inflammatory breast cancer Patients who did not undergo surgery Patients whose preoperative tumor size data is not available or deficient for analyzing
Where this trial is running
Incheon
- Incheon St. Mary's Hospital — Incheon, South Korea (RECRUITING)
Study contacts
- Study coordinator: Young-Joon Kang, Ph.D.
- Email: yjkang.md@gmail.com
- Phone: 82 32-280-5179
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Mastectomy, Breast Neoplasm Malignant Primary, Breast cancer, Ductal carcinoma in situ